Cutting through the weeds: Evaluation of a novel adsorption with crossmatch cells and elution protocol to sharpen HLA antibody identification by the single antigen bead assay

The single antigen bead (SAB) assay is the most used test for the identification of HLA specific antibodies pre- and post-transplant. Nevertheless, detection of spurious reactivities remains a recognized assay limitation. In addition, the presence of weak reactivity patterns can complicate unacceptable antigen assignment. This work presents the evaluation of the adsorption with crossmatch cells and elution (AXE) technique, which was designed to help differentiate weak HLA specific antibodies targeting native antigens from spurious and background SAB assay reactivity. The AXE protocol uses selected donor cells to adsorb HLA specific antibodies from sera of interest. Bound antibodies are then eluted off washed cells and identified using the SAB assay. Only antibodies targeting native HLA are adsorbed. Assay evaluation was performed using five cell donors and pooled positive control serum. AXE efficiency was determined by comparing SAB reactivity of adsorbed/eluted antibody to that of the antibodies in unadsorbed sera. A robust efficiency was seen across a wide range of original MFI for donor specific antibodies (DSA). A higher absorption/elution recovery was observed for HLA class I antigens vs. class II. Locus-specific variation was also observed, with high-expression HLA loci (HLA-A/B/DR) providing the best recovery. Importantly, negligible reactivity was detected in the last wash control, confirming that AXE eluates were not contaminated with HLA antibody carry-over. Donor cells incubated with autologous and DSA-containing allogeneic sera showed that AXE selectively adsorbed HLA antibodies in a donor antigen-specific manner. Importantly, antibodies targeting denatured epitopes or other non-HLA antigens were not detected by AXE. AXE was particularly effective at distinguishing weak HLA antibodies from background reactivity. When combined with epitope analysis, AXE enhanced precise identification of antibody-targeted eplets and even facilitated the characterization of a potential novel eplet. Comparison of AXE to flow cytometric crossmatching further revealed that AXE was a more sensitive technique in the detection of weak DSA. Spurious reactivities on the current SAB assay have a deleterious impact on the assignment of clinically relevant HLA specificities. The AXE protocol is a novel test that enables users to interrogate reactive patterns of interest and discriminate HLA specific antibodies from spurious reactivity.

[1]  R. Bray,et al.  Out with the old, in with the new: Virtual versus physical crossmatching in the modern era , 2019, HLA.

[2]  Robert A Bray,et al.  (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch. , 2018, Human immunology.

[3]  R. Bray,et al.  It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen. , 2017, Human immunology.

[4]  N. El-Awar,et al.  HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined , 2017, Journal of immunology research.

[5]  B. Shames,et al.  Renal Transplantation With Final Allocation Based on the Virtual Crossmatch , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  S. Lepreux,et al.  Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation , 2016, Transplantation.

[7]  J. Moreau,et al.  Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation , 2015, European journal of immunology.

[8]  C. Jacquelinet,et al.  Denatured Class I Human Leukocyte Antigen Antibodies in Sensitized Kidney Recipients: Prevalence, Relevance, and Impact on Organ Allocation , 2014, Transplantation.

[9]  R. Bray,et al.  HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  V. Thohan,et al.  Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  D. Middleton,et al.  Nothing's perfect: the art of defining HLA-specific antibodies. , 2014, Transplant immunology.

[12]  M. Verhaar,et al.  The significance of pretransplant donor‐specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation , 2013, Clinical and experimental immunology.

[13]  M. Zeier,et al.  Influence of Test Technique on Sensitization Status of Patients on the Kidney Transplant Waiting List , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  A. Webster,et al.  Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.

[15]  M. Gandhi,et al.  Positive virtual crossmatch with negative flow crossmatch results in two cases. , 2011, Transplant immunology.

[16]  J. Cecka,et al.  Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  P. Terasaki,et al.  Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. , 2009, Human immunology.

[18]  Junchao Cai,et al.  Intact HLA Not &bgr;2m-free Heavy Chain-Specific HLA Class I Antibodies Are Predictive of Graft Failure , 2009, Transplantation.

[19]  J. Steiger,et al.  Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads , 2009, Transplantation.

[20]  P. Terasaki,et al.  “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males , 2008, Transplantation.

[21]  D. Nochy,et al.  Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. , 2008, Contributions to nephrology.

[22]  D. Nochy,et al.  Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  P. Terasaki,et al.  HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. , 2007, Human immunology.

[24]  René J Duquesnoy,et al.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. , 2002, Human immunology.

[25]  L. Lebeck,et al.  The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. , 1989, Transplantation.

[26]  P. Russell,et al.  Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients. , 1978, Transplantation proceedings.

[27]  F. Whittier,et al.  A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants. , 1977, Transplantation proceedings.

[28]  P. Terasaki,et al.  Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.

[29]  D. B. Amos,et al.  A simple micro cytotoxicity test. , 1969, Transplantation.

[30]  H. Gebel,et al.  Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection. , 2018, Transplantation.

[31]  David M. Conrad,et al.  Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols. , 2018, Human immunology.

[32]  H. Perkins,et al.  Flow cytometry analysis: A high technology cross-match technique facilitating transplantation , 1983 .